Blood Markers Study for Heart Disease and Blood Clot Risk
Part of Heart & circulation clinical trials.
This study examines new blood markers to predict blood clot and bleeding risks in patients with heart disease taking blood thinners. Understanding these markers may help doctors better predict complications and adjust treatment for individual patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Hospitalized with heart disease symptoms and need long-term blood thinner medication
- Diagnosed with either acute heart attack or stable heart disease treated with heart stent (PCI)
- Clinically stable and ready for hospital discharge after treatment
- Willing to provide blood samples and participate in follow-up visits
- No serious life-threatening conditions expected in the next 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors monitor and guide treatment for people with heart disease who have had a stent placed. It focuses on finding the best ways to manage blood-thinning medications to reduce risks of bleeding and clotting.
This trial is checking whether current tools can accurately predict bleeding and clotting risks in people with coronary heart disease who are on long-term blood thinners. It aims to help doctors make safer treatment decisions.
This study looks at blood “biomarkers” (signals in blood tests) in people who arrive with symptoms that could be a heart attack. It may help doctors spot and manage acute heart problems sooner and more accurately.
This study looks at two blood markers (mean platelet volume and systemic inflammatory response index) to see if they help predict outcomes in people admitted with a heart attack or unstable angina. If you've had chest pain from a heart condition and get to the hospital quickly, this could be relevant for you.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
This study collects blood samples from people with various health conditions to help develop new diagnostic tests. It aims to see how well these tests work and could lead to better tools for diagnosing conditions like heart disease, diabetes, and infections.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.